Prospective study of the relationship between coffee and tea with colorectal cancer risk: The PLCO Cancer Screening Trial

British Journal of Cancer

Volumn 109, Issue 5, 2013, Pages 1352-1359

  Dominianni, C ^a,b   Huang, W Y ^c   Berndt, S ^c   Hayes, R B ^a,b   Ahn, J ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

coffee; tea; colorectal cancer; prospective; PLCO

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RISK; CANCER SCREENING; CANCER STAGING; COFFEE; COLORECTAL CANCER; FEMALE; FOLLOW UP; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TEA;

CAFFEINE; COFFEE; COLORECTAL NEOPLASMS; FEMALE; FOOD HABITS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; TEA;

EID: 84883742882     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.434     Document Type: Article

References (47)

1. American Cancer Society (2011) Colorectal cancer facts and figures 2011-2013.
2. Bernstein C, Holubec H, Bhattacharyya AK, Nguyen H, Payne CM, Zaitlin B, Bernstein H (2011) Carcinogenicity of deoxycholate, a secondary bile acid. Arch Toxicol 85: 863-871.
3. Bessler H, Salman H, Bergman M, Djaldetti M (2012) Caffeine alters cytokine secretion by PBMC induced by colon cancer cells. Cancer Invest 30: 87-91.
4. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L (1986) A data-based approach to diet questionnaire design and testing. Am J Epidemiol 124: 453-469. (Pubitemid 16047362)
5. Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, Schilter B (2002) Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 40: 1155-1163. (Pubitemid 34626880)
6. Cox DR (1972) Regression models and life-tables. J R Stat Soc Ser B 34: 187-18.
7. Galeone C, Turati F, La Vecchia C, Tavani A (2010) Coffee consumption and risk of colorectal cancer: a meta-analysis of case-control studies. Cancer Causes Control 21: 1949-1959.
8. Goldbohm RA, Hertog MG, Brants HA, van Poppel G, van den Brandt PA (1996) Consumption of black tea and cancer risk: a prospective cohort study. J Natl Cancer Inst 88: 93-100. (Pubitemid 26020097)
9. Hartman TJ, Tangrea JA, Pietinen P, Malila N, Virtanen M, Taylor PR, Albanes D (1998) Tea and coffee consumption and risk of colon and rectal cancer in middle-aged Finnish men. Nutr Cancer 31: 41-48. (Pubitemid 28345975)
10. Heilbrun LK, Nomura A, Stemmermann GN (1986) Black tea consumption and cancer risk: a prospective study. Br J Cancer 54: 677-683. (Pubitemid 17182699)
11. Huber WW, Teitel CH, Coles BF, King RS, Wiese FW, Kaderlik KR, Casciano DA, Shaddock JG, Mulder GJ, Ilett KF, Kadlubar FF (2004) Potential chemoprotective effects of the coffee components kahweol and cafestol palmitates via modification of hepatic N-acetyltransferase and glutathione S-transferase activities. Environ Mol Mutagen 44: 265-276. (Pubitemid 39447230)
12. Jacobsen BK, Bjelke E, Kvale G, Heuch I (1986) Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. J Natl Cancer Inst 76: 823-831. (Pubitemid 16121938)
13. Je Y, Liu W, Giovannucci E (2009) Coffee consumption and risk of colorectal cancer: a systematic review and meta-analysis of prospective cohort studies. Int J Cancer 124: 1662-1668.
14. Kang NJ, Lee KW, Kim BH, Bode AM, Lee HJ, Heo YS, Boardman L, Limburg P, Dong Z (2011) Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK. Carcinogenesis 32: 921-928.
15. Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S (2007) Coffee consumption and risk of colorectal cancer in a population-based prospective cohort of Japanese men and women. Int J Cancer 121: 1312-1318. (Pubitemid 47293799)
16. Li G, Ma D, Zhang Y, Zheng W, Wang P (2012) Coffee consumption and risk of colorectal cancer: a meta-analysis of observational studies. Public Health Nutr 16: 1-12.
17. Merighi S, Benini A, Mirandola P, Gessi S, Varani K, Simioni C, Leung E, Maclennan S, Baraldi PG, Borea PA (2007) Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells. Mol Pharmacol 72: 395-406. (Pubitemid 47124120)
18. Michels KB, Willett WC, Fuchs CS, Giovannucci E (2005) Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer. J Natl Cancer Inst 97: 282-292. (Pubitemid 40310276)
19. Mukhtar H, Ahmad N (2000) Tea polyphenols: prevention of cancer and optimizing health. Am J Clin Nutr 71: 1698S-1702S; discussion 1703S-1694S.
20. Nagano J, Kono S, Preston DL, Mabuchi K (2001) A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). Cancer Causes Control 12: 501-508. (Pubitemid 32735122)
21. Nakachi K, Matsuyama S, Miyake S, Suganuma M, Imai K (2000) Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors 13: 49-54. (Pubitemid 32107344)
22. Nilsson LM, Johansson I, Lenner P, Lindahl B, Van Guelpen B (2010) Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer Causes Control 21: 1533-1544.
23. Oba S, Shimizu N, Nagata C, Shimizu H, Kametani M, Takeyama N, Ohnuma T, Matsushita S (2006) The relationship between the consumption of meat, fat, and coffee and the risk of colon cancer: a prospective study in Japan. Cancer Lett 244: 260-267. (Pubitemid 44485887)
24. Patel R, Ingle A, Maru GB (2008) Polymeric black tea polyphenols inhibit 1, 2-dimethylhydrazine induced colorectal carcinogenesis by inhibiting cell proliferation via Wnt/beta-catenin pathway. Toxicol Appl Pharmacol 227: 136-146. (Pubitemid 351179849)
25. Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, Fogel R, Gelmann EP, Gilbert F, Hasson MA, Hayes RB, Johnson CC, Mandel JS, Oberman A, O'Brien B, Oken MM, Rafla S, Reding D, Rutt W, Weissfeld JL, Yokochi L, Gohagan JK (2000) Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 21: 273S-309S.
26. Ruiz del Castillo ML, Herraiz M, Blanch GP (1999) Rapid analysis of cholesterol-elevating compounds in coffee brews by off-line highperformance liquid chromatography/high-resolution gas chromatography. J Agric Food Chem 47: 1525-1529. (Pubitemid 29217150)
27. Sengupta A, Ghosh S, Das RK, Bhattacharjee S, Bhattacharya S (2006) Chemopreventive potential of diallylsulfide, lycopene and theaflavin during chemically induced colon carcinogenesis in rat colon through modulation of cyclooxygenase-2 and inducible nitric oxide synthase pathways. Eur J Cancer Prev 15: 301-305. (Pubitemid 44060487)
28. Shimizu M, Shirakami Y, Sakai H, Adachi S, Hata K, Hirose Y, Tsurumi H, Tanaka T, Moriwaki H (2008) (-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice. Cancer Prev Res (Philadelphia) 1: 298-304.
29. Simons CC, Leurs LJ, Weijenberg MP, Schouten LJ, Goldbohm RA, van den Brandt PA (2010) Fluid intake and colorectal cancer risk in the Netherlands Cohort Study. Nutr Cancer 62: 307-321.
30. Sinha R, Cross AJ, Daniel CR, Graubard BI, Wu JW, Hollenbeck AR, Gunter MJ, Park Y, Freedman ND (2012) Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study. Am J Clin Nutr 96: 374-381.
31. Su LJ, Arab L (2002) Tea consumption and the reduced risk of colon cancer-results from a national prospective cohort study. Public Health Nutr 5: 419-425. (Pubitemid 34614909)
32. Subar AF, Midthune D, Kulldorff M, Brown CC, Thompson FE, Kipnis V, Schatzkin A (2000) Evaluation of alternative approaches to assign nutrient values to food groups in food frequency questionnaires. Am J Epidemiol 152: 279-286. (Pubitemid 30640251)
33. Sukhthankar M, Alberti S, Baek SJ (2010) (-)-Epigallocatechin-3-gallate (EGCG) post-transcriptionally and post-translationally suppresses the cell proliferative protein TROP2 in human colorectal cancer cells. Anticancer Res 30: 2497-2503.
34. Sun CL, Yuan JM, Koh WP, Lee HP, Yu MC (2007) Green tea and black tea consumption in relation to colorectal cancer risk: the Singapore Chinese Health Study. Carcinogenesis 28: 2143-2148. (Pubitemid 47543374)
35. Sun CL, Yuan JM, Koh WP, Yu MC (2006) Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis 27: 1301-1309. (Pubitemid 43985404)
36. Suzuki Y, Tsubono Y, Nakaya N, Koizumi Y, Shibuya D, Tsuji I (2005) Green tea and the risk of colorectal cancer: pooled analysis of two prospective studies in Japan. J Epidemiol 15: 118-124. (Pubitemid 41403849)
37. Terry P, Wolk A (2001) Tea consumption and the risk of colorectal cancer in Sweden. Nutr Cancer 39: 176-179. (Pubitemid 33694032)
38. US Department of Agriculture (CSFII) (1997) Design and operation: the continuing survey of food intakes by individuals and the diet and health knowledge survey, 1994-1996.Nationwide Food Surveys Report No. 96-1,US Department of Agriculture, Agricultural Research Service.
39. Wang ZH, Gao QY, Fang JY (2012) Green tea and incidence of colorectal cancer: evidence from prospective cohort studies. Nutr Cancer 64: 1143-1152.
40. Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Church T, Yurgalevitch S, Austin JH, Prorok PC, Gohagan JK (2005) Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst 97: 989-997.
41. Willett W (1998) Nutritional Epidemiology. Oxford University Press.
42. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122: 51-65. (Pubitemid 15010435)
43. Xu M, Bailey AC, Hernaez JF, Taoka CR, Schut HA, Dashwood RH (1996) Protection by green tea, black tea, and indole-3-carbinol against 2-amino-3-methylimidazo[4,5-f]quinoline-induced DNA adducts and colonic aberrant crypts in the F344 rat. Carcinogenesis 17: 1429-1434. (Pubitemid 26242646)
44. Yang G, Shu XO, Li H, Chow WH, Ji BT, Zhang X, Gao YT, Zheng W (2007) Prospective cohort study of green tea consumption and colorectal cancer risk in women. Cancer Epidemiol Biomarkers Prev 16: 1219-1223. (Pubitemid 46984962)
45. Yang G, Zheng W, Xiang YB, Gao J, Li HL, Zhang X, Gao YT, Shu XO (2011) Green tea consumption and colorectal cancer risk: a report from the Shanghai Men's Health Study. Carcinogenesis 32: 1684-1688.
46. Zhang X, Albanes D, Beeson WL, van den Brandt PA, Buring JE, Flood A, Freudenheim JL, Giovannucci EL, Goldbohm RA, Jaceldo-Siegl K, Jacobs EJ, Krogh V, Larsson SC, Marshall JR, McCullough ML, Miller AB, Robien K, Rohan TE, Schatzkin A, Sieri S, Spiegelman D, Virtamo J, Wolk A, Willett WC, Zhang SM, Smith-Warner SA (2010) Risk of colon cancer and coffee, tea, and sugar-sweetened soft drink intake: pooled analysis of prospective cohort studies. J Natl Cancer Inst 102: 771-783.
47. Zheng W, Doyle TJ, Kushi LH, Sellers TA, Hong CP, Folsom AR (1996) Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women. Am J Epidemiol 144: 175-182. (Pubitemid 26234996)